Michael Thomas Henderson is Chief Executive Officer of Apogee Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Spyre Therapeutics, Inc.
16 May 24
4
Apogee Therapeutics, Inc.
20 Dec 23
3/A
Apogee Therapeutics, Inc.
17 Jul 23
3
Apogee Therapeutics, Inc.
13 Jul 23
3
Aeglea BioTherapeutics, Inc.
30 Jun 23
3
ARYA Sciences Acquisition Corp IV
25 Feb 21
4
BridgeBio Pharma, Inc.
17 Dec 20
4
BridgeBio Pharma, Inc.
2 Dec 20
4
BridgeBio Pharma, Inc.
2 Dec 20
4
BridgeBio Pharma, Inc.
18 Nov 20
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 May 24 | SYRE Spyre Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 39.29 | 11,323 | 444.88 k | 11,323 |
18 Dec 23 | APGE Apogee Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 22.86 | 398,512 | 9.11 mm | 398,512 |